BCAL Diagnostic Commences Phased Australian Rollout of Avantect Multi-Cancer Blood Test

BCAL Diagnostics ASX:BDX has commenced the phased Australian market rollout of the Avantect blood-based test for the non-invasive detection of cancer-associated signals across multiple cancer types.Initial distribution will take place in New South Wales and Victoria, supported through telehealth an…